Oriola Oyj
LSE:0NES
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one 0NES stock under the Base Case scenario is 9.2243 EUR. Compared to the current market price of 2.3425 EUR, Oriola Oyj is Undervalued by 75%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Oriola Oyj.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Oriola Oyj
Balance Sheet Decomposition
Oriola Oyj
| Current Assets | 614m |
| Cash & Short-Term Investments | 107.6m |
| Receivables | 316.7m |
| Other Current Assets | 189.7m |
| Non-Current Assets | 309.4m |
| Long-Term Investments | 205.8m |
| PP&E | 43.2m |
| Intangibles | 43.7m |
| Other Non-Current Assets | 16.7m |
| Current Liabilities | 750.6m |
| Accounts Payable | 685.2m |
| Short-Term Debt | 17.9m |
| Other Current Liabilities | 47.5m |
| Non-Current Liabilities | 54.9m |
| Long-Term Debt | 38.9m |
| Other Non-Current Liabilities | 16m |
Free Cash Flow Analysis
Oriola Oyj
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Oriola Oyj
|
Revenue
|
1.8B
EUR
|
|
Cost of Revenue
|
-1.7B
EUR
|
|
Gross Profit
|
166.5m
EUR
|
|
Operating Expenses
|
-162.8m
EUR
|
|
Operating Income
|
3.7m
EUR
|
|
Other Expenses
|
-30.8m
EUR
|
|
Net Income
|
-27.1m
EUR
|
0NES Profitability Score
Profitability Due Diligence
Oriola Oyj's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
Score
Oriola Oyj's profitability score is 34/100. The higher the profitability score, the more profitable the company is.
0NES Solvency Score
Solvency Due Diligence
Oriola Oyj's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
Oriola Oyj's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
0NES Price Targets Summary
Oriola Oyj
According to Wall Street analysts, the average 1-year price target for 0NES is 1.3028 EUR with a low forecast of 1.2648 EUR and a high forecast of 1.3675 EUR.
Dividends
Current shareholder yield for OKDBV is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one 0NES stock under the Base Case scenario is 9.2243 EUR.
Compared to the current market price of 2.3425 EUR, Oriola Oyj is Undervalued by 75%.